Skip to content
The Nexus
BUSINESSAug 13 · 11:49 UTCWTOP DCWTOP Staff

Karyopharm Therapeutics: Q2 Earnings Snapshot

Karyopharm Therapeutics reported a loss of $67 million and $2.32 per share in its second quarter. The company posted revenue of $33.4 million during the period and anticipates full-year revenue between $130 million to $150 million.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned
Karyopharm Therapeutics Inc.organizationNewtonplaceMass.place$67 milliontopic$2.32 per sharetopic$33.4 milliontopic
Spot something wrong with this article?Report a problem →
Forward this
Related Signal

Adjacent reporting